Quantitative Systematic Strategies’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,305
Closed -$53K 578
2019
Q4
$53K Hold
10,305
0.01% 528
2019
Q3
$25K Sell
10,305
-9,996
-49% -$26.5K 0.01% 449
2019
Q2
$44K Buy
20,301
+9,459
+87% +$22.4K 0.01% 458
2019
Q1
$29K Sell
10,842
-62,643
-85% -$271K 0.01% 373
2018
Q4
$353K Buy
73,485
+61,686
+523% +$374K 0.08% 356
2018
Q3
$112K Sell
11,799
-1,705
-13% -$16.4K 0.02% 566
2018
Q2
$131K Buy
13,504
+1,540
+13% +$16.2K 0.02% 586
2018
Q1
$126K Buy
+11,964
New +$118K 0.03% 591

Other funds holding IMGN

Quantitative Systematic Strategies's IMGN Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 10,305 shares — an estimated $53K sold.

Quantitative Systematic Strategies first reported a position in IMGN in Q1 2018 and held it in 8 quarters. The position peaked at $353K in Q4 2018. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • Quantitative Systematic Strategies reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,305 Immunogen Inc shares in Q1 2020, an estimated $53K.
  • Quantitative Systematic Strategies first reported a position in Immunogen Inc in Q1 2018 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Immunogen Inc position peaked at $353K in Q4 2018.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.